IL33 and infection: Beginning at 1 dpi, IL-33 was administered i.p. every 2 days until 7 dpi, which resulted in a dose-dependent reduction in the frequency of infected cells at the site of infection and a decrease in parasite DNA in multiple tissues (Figure 4A).